Purpose: Cytolethal distending toxin (CDT) considered as a key factor of localized aggressive periodontitis, endocarditis, meningitis, and osteomyelitis is composed of five open reading frames (ORFs). Among of them, the individual role of CdtA and CdtC is not clear; several reports presents that CDT is an AB2 toxin and they enters the host cell via clathrin-coated pits or through the interaction with GM3 ganglioside. So, CdtA, CdtC, or both seem to be required for the delivery of the CdtB protein into the host cell. Moreover, recombinant CDT was suggested as good vaccine material and antibody against CDT can be used for neutralization or for a detection kit.
Introduction
Cytolethal distending toxin (CDT) was first reported as a toxin in Escherichia coli by Johnson and Lior 1) .
The new toxin was designated as ʻcytolethal distending toxinʼ to reflect the morphologic change associated with its activity on host cell. Also, CDT has a unique mechanism of host cell DNA damage, leading to cell cycle arrest inducing apoptosis 2) . To date, CDTs of various gram-negative bacterial species such as Campylobacter Jejuni, Aggregatibacter actinomycetemcomitans, and Haemophilus ducreyi are possible virulence factors, because of their cytolethal effect and associations with disease such as enteritis, hepatitis, gastroenteritis, chancroids, localized aggressive periodontitis, endocarditis, meningitis, and osteomyelitis [3] [4] [5] .
A. actinomycetemcomitans is the only oral bacterium identified to produce a CDT 6, 7) . The CDT gene of A. actinomycetemcomitans is composed of five open reading frames (ORFs): orf1, orf2, cdtA, cdtB, and cdtC 8) . The orf1 and orf2 located upstream of the cdtA gene are probably transcribed together with the three cdt genes. Still, it is not known whether orf1 and orf2 are actually translated in vivo. Although the individual role of CdtA and CdtC is not clear, several reports presents that CDT is an AB2 toxin (CdtB, the enzymatically active subunit A; CdtA and CdtC, the heterodimeric subunit B) 9) . Moreover, previous studies showed that CDT enters the host cell via clathrin-coated pits Production of the polyclonal subunit C protein antibody against Aggregatibacter actinomycetemcomitans cytolethal distending toxin or through the interaction with GM3 ganglioside 10) . So, many other research groups suggest that CdtA, CdtC, or both seem to be required for the delivery of the CdtB protein into the host cell and also contribute to the cell cycle arrest 3, [11] [12] [13] [14] . Frisk et al. 15) suggest that CdtA and/or CdtC are the components of the holotoxin which anchor to the cell surfaces or act as a carrier for CdtB to internalize this subunit into the cells and to elicit its cellular toxicity. Cope et al. 16) proved that a monoclonal antibody against CdtC was able to hamper the toxic activity of CDT of H. ducreyi.
Recombinant CDT was good vaccine material and antibody against CDT can be used for neutralization or for a detection kit. More interestingly, there is a possibility of using CDT as a mucosal adjuvant through its binding activity to cell surface receptor 17) . Up to now, cholera toxin or enterotoxic E. coli toxin has been mainly utilized as a mucosal adjuvant but these toxins belong to AB5 family, while CDT to AB2.
Development of a new mucosal adjuvant will be more feasible by using CDT due to its structural simplicity or lesser toxicity.
Expression of toxins is tightly controlled during the growth phase of pathogens and associates with the virulent activity of toxins. For example, Apx protein of Actinobacillus pleuropneumoniae has hemolytic activity and was differentially expressed through the growth curve 18) . .
Expression and Purification of recombinant CdtC
Each colony of E. coli BL21 (DE3) transferred with the pET28a-cdtC plasmid was cultured into 5ml LB broth containing 50ug/ml kanamycine and incubated at Induced bacteria were harvested using centrifugation, and then the pellet was resuspended in 20mM
Tris-HCl containing 0.5M NaCl, and 5mM imidazole (pH 8.0). The resuspended bacteria were disrupted with an ultrasonic disruptor 9, 20) . 
Production of polyclonal anti-CdtC antibody
To generate anti-CdtC serum, BALB/c mice were immunized at day 1 with CdtC emulsified with Freund complete adjuvant and 2 weeks later with CdtC emulsified with Freund incomplete adjuvant. Antisera were obtained 5 weeks after first injection.
SDS-PAGE and Western blot
Bacterial lysate or purified recombinant CdtC was resolved by SDS-PAGE and transferred to nitrocellulose paper for Western blot analysis with polyclonal anti-CdtC antibody as previously described 7) .
The transferred nitrocellulose membrane was blocked by 5% skim milk at room temperature for 1 h and then incubated with polyclonal anti-CdtC antibody (1:100 or 1:1000 dilution) for another hour. After the nitrocellulose membrane was incubated with anti-mouse IgG conjugated to horseradish peroxidase for 1h and then developed into the film using chemiluminescence (ECL) for 3min.
ELISA (Enzyme-Linked ImmunoSorbent Assay)
Recombinant CDT subunit protein or culture supernatant of A. actinomycetemcomitans Y4 resuspended in carbonate-bicarbonate buffer were used to coat ELISA plate at 37ﾟC for 2 h and the coated plates was blocked by 1% skim milk. After washed using PBS (pH .
To obtain the anti CdtC sera, we bleed the immunized mice at 3 and 5 week. We tested whether these anti-CdtC sera may contain the specific antibody against recombinant CdtC subunit using Western blotting. The drawn antiserum clearly recognized recombinant CdtC protein (Fig. 1) . Moreover, the antiserum reacted also to a native CdtC (17.4 kDa) in bacterial lysate of A. actinomycetemcomitans Y4 but not to the non-related protein, recombinant AgI/II fragment of Streptococcus mutans (Fig. 2) . These results suggested that the serum contain the anti-CdtC antibody binding to the recombinant CdtC protein and native CdtC as well.
ELISA condition for anti-CdtC antibody
ELISA condition for anti-CdtC sera was tested to detect native CDT protein 23) . ELISA plate coated by recombinant CdtC protein (100ng) was incubated with antiserum 1:100 or 1:1000 for 2h. After incubation of anti mouse IgG-AP and then AP substrate, the color intensity was monitored at 405nm every 10, 30, 60, 90, and 100min using spectrophotometer. When color density was compared, anti-CdtC polyclonal antibody (1:100 dilutions) distinguished the recombinant CdtC protein (100ng) since 10min and these results were confirmed serial dilution of anti-CdtC antibody (Fig.   3 ). At a higher dilution (1:1000), anti-CdtC polyclonal antibody also distinguished the recombinant CdtC protein (100ng) since 30min (Fig. 4) . These data were converted in reciprocal Log2 titer and the reaction pattern and sensitivity of anti-CdtC polyclonal antibody compared (Fig. 5) . (Fig. 7) . (Fig. 8A ) 17, 22) . The culture supernatants and cell lysate were prepared (6, 9, 24, and 30h) and then analyzed using Western blotting. Although anti-CdtC polyclonal antibody had not detected the native CdtC subunit in the culture supernatant of A. actinomycetemcomitans Y4, native CdtC subunit was increased in a time-dependent way in cell lysate (Fig.   8B) . Also, the protein band of holotoxin size was detected at 24 h cell lysate sample (Fig. 8C ). This result implied that native CdtC were piled up on the cell membrane or periplasm and holotoxin assembly were maximized around late-log phase (Fig. 8) . A. actinomycetemcomitans Y4 was prepared at 6, 9, 24, and 30h. CdtC subunit (B) was detected at 14 kDa and CDT holotoxin (C) was detected at 74kDa. All samples were separated on SDS-PAGE gel and transferred to nitrocellulose membrane followed by development using anti-CdtC antibody.
Discussion
Aggregatibacter actinomycetemcomitans was associated with localized aggressive periodontitis, endocarditis, meningitis, and osteomyelitis. The CDT was considered as a key factor of these diseases 3, [11] [12] 24) . Also, recent studies have shown that A. actinomycetemcomitans CDT inhibit human gingival fibroblasts, Chinese hamster ovary, monkey fibroblasts Another ELISA also revealed that the anti-CdtC antibody detects native CdtC protein from the bacterial culture supernatant (Fig. 6) . For unknown reason, CdtC subunit from around log phase sample was better detected in ELISA than in Western blotting.
An enzymatic subunit of the CDT, CdtB has been known to be internalized into the host cell in order to induce its genotoxic effect. However, CdtB cannot be localized in host cytoplasm without the help of a heterodimeric complex consisting of CdtA and CdtC. So, some studies suggested that CdtC functions as a ligand to interact with GM3 ganglioside of host cell surface 10, 21) . Other toxin such as Apx of Actinobacillus pleuropneumoniae has been known to be expressed at specific phase of growth 18) . Similarly, this study proved that the expression of CdtC subunit was regulated according to the bacterial growth phase. CdtC protein of the bacterial lysates started to show up in early log phase and its expression was maximized in late log phase, while CdtC expression in the culture supernatant was not clear. Interestingly, a protein band at the higher molecular weight than CdtC subunit existed for a short time around late log phase.
These results implied that CDT expression is tightly controlled during the growth phase and CDT can be stable for a short period after its secretion since CDT was not detected from the sample from the over-grown culture (Fig. 8 ).
In conclusion, we produced polyclonal anti-CdtC antibody which interacts specifically with recombinant CdtC, native CdtC, or CDT holotoxin as confirmed by Western blot and ELISA. Interestingly, CDT holotoxin existed at 24h but not at 48h, meaning that CDT holotoxin was assembled at specific time during the bacterial growth.
